OBJECTIVE	To determine whether genotypes at 2 major loci associated with late age-related macular degeneration ( AMD ) , complement factor H ( CFH ) and age-related maculopathy susceptibility 2 ( ARMS2 ) , influence the relative benefits of Age-Related Eye Disease Study ( AREDS ) supplements .\